SCHEMBL11934023

SCHEMBL11934023

Cc1cccc(-c2nnc(-c3cccc(-n4c5ccccc5c5ccccc54)c3)o2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 8/20 0.61
▸ HPGD P15428 7/20 0.61
▸ NPC1 O15118 7/20 0.61
▸ RAB9A P51151 7/20 0.61
▸ TSHR P16473 3/20 0.61
▸ ALDH1A1 P00352 5/20 0.52
▸ POLB P06746 3/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ TP53 P04637 2/20 0.52
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CYP1A2 P05177 3/20 0.45
▸ L3MBTL1 Q9Y468 3/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.44
▸ ACHE P22303 1/20 0.44
▸ BACE1 P56817 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10820029 0.93 SMN1; SMN2 (0.52) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL21312049 0.92 KDM4E (0.48) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL10820027 0.91 NPC1 (0.56) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL11934025 0.91 NPC1 (0.64) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4651756 0.89 NPC1 (0.52) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL10820024 0.87 SMN1; SMN2 (0.46) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4546813 0.85 L3MBTL1 (0.52) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL10820036 0.85 NPC1 (0.60) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL17125595 0.85 NPC1 (0.46) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4546817 0.84 L3MBTL1 (0.50) SMN1; SMN2NPC1RAB9ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569311-B1 AMBIPOLAR SMALL MOLECULE HOSTS FOR PHOSPHORESCENT GUEST EMITTERS GEORGIA TECH RES INST (US) 2016-01-13 — — EP disclosed
US-9133177-B2 Ambipolar small molecule hosts for phosphorescent guest emitters GEORGIA TECH RESEARCH CORPORATION (US) 2015-09-15 — — US disclosed
US-20120168732-A1 AMBIPOLAR SMALL MOLECULE HOSTS FOR PHOSPHORESCENT GUEST EMITTERS GEORGIA TECH RESEARCH CORPORATION (US) 2012-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120168732-A1 AMBIPOLAR SMALL MOLECULE HOSTS FOR PHOSPHORESCENT GUEST EMITTERS OCIAD2, OCIAD1, ORC3 SMN1; SMN2 4781/4885HPGD 3266/4885NPC1 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback